Spotlight Growth
No Result
View All Result
Friday, February 3, 2023
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
No Result
View All Result
No Result
View All Result
Home Bio/Med/Pharma

3 Smallcap NASDAQ Warrants to Keep an Eye On

by admin
August 2, 2018
in Bio/Med/Pharma, Financials, Opinion
0
3 Smallcap NASDAQ Warrants to Keep an Eye On

Smallcap Warrants To Keep An Eye On Opinion

Investors often overlook warrants as an investment vehicle. But warrants can offer leverage, especially in stocks without options, that you can’t get otherwise.

These small-cap warrants could offer up big returns if the companies execute their plans. Taking a small position is one of the best way to ensure you monitor these high potential warrants.

Purple Innovation Warrants, Source: Nasdaq.com
Purple Innovation Warrants, Source: Nasdaq.com

Purple Innovations, Inc. (NASDAQ: PRPL) is a unique mattress maker founded by two brothers. One is an aerospace materials engineer, and the other a manufacturing and design expert. The Pearce brothers originally made cushioning for wheelchairs. They have grown the company over many years to make several “cushion” related items, and have recently moved into manufacturing mattresses.

Their company was purchased by a special purpose acquisition company (or SPAC) in early 2018, providing a cash infusion to the company. This made warrants available on the company, under the symbol “PRPLW,” for the first time. The warrants are exercisable at $11.50 per share.

The stock has struggled this year in adjusting to the new business structure. But, the company has recently signed deals with Mattress Firm to offer mattresses in retail stores. Moving from a mail order company to selling their product in retail locations should provide a stock boost.

The company has grown earnings this year 141% and has increased quarterly year-over-year revenue by over 100%. Investors can pick up the warrant before the market realizes the value being built in the company.

National Holdings Corp Warrants, Source: Nasdaq.com
National Holdings Corp Warrants, Source: Nasdaq.com

Recent market struggles have many analysts anticipating a move from growth to value in the second half of the year. This rotation, combined with increasing interest rates, makes the warrants of National Holdings Corporation (NASDAQ: NHLD) a buy.

National Holdings spiked earlier in the year to around $5 as news of the Fed raising interest rates more aggressively permeated the markets. The stock has since drifted down close to $3. The warrants trade under the symbol “NHLDW,” are exercisable at $3.25, and expire in January 2022.

With the warrants trading at just $1, a move back to $5 in the common would have the warrants doubling. The company has grown earnings per share 324% this year, and even now trades below book value of $3.69 a share. As always, investors should use limit orders in the thinly traded securities to build a position.

Motif Bio Plc Warrants, Source: Nasdaq.com
Motif Bio Plc Warrants, Source: Nasdaq.com

Motif Bio Plc (NASDAQ: MTFB) is an American Depository Receipt (ADR) that trades on the Nasdaq market. The company is working on “antibiotics to treat patients with serious or life-threatening infections caused by multi-drug resistant bacteria.” Because of the nature of their product it is receiving priority review by the FDA.

The company has applied for marketing approval for clinical trials, and expects a response from the FDA to come any day. Motif warrants trade under the symbol “MTFBW,” are exercisable at $8.03, and expire in November 2021.

Over the last year the warrants have traded down from the $6 range to their current $2.50. While more risky than the other two warrants mentioned here, the risk / reward profile is greater. This is exactly the type of warrant trade that can result in large gains if the company receives good news from the FDA. Again, only limit orders should be employed here.

All three of these warrants, Purple, National Holdings, and Motif, have their own value and risk profiles that make them good investments for the right portfolio. Pick the one that fits your goals and add a leveraged boost to your returns.

Disclaimer: The author and Spotlight Growth has no positions in any of the stocks mentioned in this article. Nor does either party currently have any relationship, or any other conflicts of interest, with any of the companies mentioned in this article. This content is meant for informational and entertainment purposes only and should not be meant as a recommendation to buy or sell any securities. Please visit a licensed financial representative to determine what investments are right for you.

Article By: Steven Adams

Tags: biopharmaceuticalsbiotechcommon stockconsumer goodseditorialemerging growthfinancialsinvestinginvestmentmanufacturingmedicalmicrocap stocksNASDAQnewsopinionpharmaceuticalspublic companysalesservicessmall cap companiessmall cap stockssmall capssmallcapsSpotlight GrowthSpotlight Growth Stockstradingtreatmentwarrants
  • Trending
  • Comments
  • Latest
Asure Software NASDAQ ASUR Human Capital Management HCM Industry Spotlight Growth

Asure Software (NASDAQ: ASUR) is Expanding to Meet the Rising Demand for Human Capital Management Software

September 27, 2022
OLB Group NASDAQ OLB Cuentas NASDAQ CUEN Partnership Fintech Spotlight Growth

OLB Group (NASDAQ: OLB) and Cuentas (NASDAQ: CUEN) Team Up to Bring Fintech Solutions to Over 32,000 Bodegas Across the United States

October 6, 2022
Siyata Mobile NASDAQ SYTA SYTAW SD7 VK7 Purchase Orders Spotlight Growth

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

December 14, 2021
Telcoin TEL Crypto Spotlight Growth

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

June 15, 2021
Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

0
Safe-T SFET NASDAQ UN Presentation

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

0
Safe-T Group SFET Q4 FY 2020 Financial Results

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

0
Safe-T Group NASDAQ SFET FY 2020 Prelim

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

0
Elys Game Technology Corp NASDAQ ELYS Completes Acquisition of Engage IT Services Spotlight Growth

Elys Game Technology Corp (NASDAQ: ELYS) Completes Acquisition of Engage IT Services, a Software Engineering and IT Development Company

February 2, 2023
Tenax Therapeutics NASDAQ TENX US Patent Levosimendan PH-HFpEF Spotlight Growth

Tenax Therapeutics (NASDAQ: TENX) Granted U.S. Patent for IV Levosimendan for Pulmonary Hypertension with Heart Failure and Preserved Ejection Fraction (PH-HFpEF)

February 2, 2023
Versus Systems NASDAQ VS Resolve Debt Partner AI Gamification Consumer Debt Spotlight Growth

Versus Systems (NASDAQ: VS) and Resolve Debt Partner to Integrated Generative AI and Gamification to Customer Payments and Credit Markets

February 1, 2023
Finding the Most Accurate Technical Analysis Indicator Spotlight Growth

Finding the Most Accurate Technical Analysis Indicator

January 31, 2023
ADVERTISEMENT

Recent News

Elys Game Technology Corp NASDAQ ELYS Completes Acquisition of Engage IT Services Spotlight Growth

Elys Game Technology Corp (NASDAQ: ELYS) Completes Acquisition of Engage IT Services, a Software Engineering and IT Development Company

February 2, 2023
Tenax Therapeutics NASDAQ TENX US Patent Levosimendan PH-HFpEF Spotlight Growth

Tenax Therapeutics (NASDAQ: TENX) Granted U.S. Patent for IV Levosimendan for Pulmonary Hypertension with Heart Failure and Preserved Ejection Fraction (PH-HFpEF)

February 2, 2023

Categories

  • Bio/Med/Pharma
  • Cannabis
  • Commodities
  • Consumer Goods
  • Crowdfunding
  • Crypto Cheat Sheets
  • Cryptocurrency
  • Earnings
  • Education
  • Entertainment
  • Financials
  • Market News
  • Opinion
  • Politics
  • Real Estate
  • Split Watch
  • Sponsored
  • Store
  • Technology
  • Uncategorized
  • Venture Capital/Private Equity (VC/PE)

Site Navigation

  • Disclosures
  • Terms Of Service
  • Privacy Policy
  • Contact Us

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

No Result
View All Result
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

Newsletter Signup

Subscribe to our weekly newsletter below and never miss the latest small/micro-cap analysis and investment news from Spotlight Growth.

Enter your email address

Thanks, I’m not interested